axsome.com
US medical affairs
This website is intended for US healthcare professionals only.

congress
presentations

American Association of Psychiatric Pharmacists (AAPP) 2024 Annual Meeting

Orlando, FL
April 7-10, 2024

PDF screenshot

AXS-05 | Major Depressive Disorder

Efficacy, Tolerability, and Safety of AXS-05, a Novel Oral Antidepressant: Data from 3 Clinical Trials
view/download
 
Dr. Craig Chepke, MD, DFAPA describes the “Efficacy, Tolerability, and Safety of AXS-05, a Novel Oral Antidepressant: Data from 3 Clinical Trials” AAPP 2024 poster
view
PDF screenshot

AXS-05 | Major Depressive Disorder

Impact of AXS-05, an Oral NMDA Receptor Antagonist, on Anhedonic Symptoms in Major Depressive Disorder
view/download
 
Dr. Roger S McIntyre, MD, FRCPC describes the “Impact of AXS-05, an Oral NMDA Receptor Antagonist, on Anhedonic Symptoms in Major Depressive Disorder” AAPP 2024 poster
view